INM InMed Pharmaceuticals Inc.

BULLISH Impact: 7/10 Insider Cluster (2 insiders)
Horizon weeks Filed Jun 11, 2026 Processed 4d 8h ago
Insider cluster: 2 insiders, $189K total

Price Chart

Loading chart...

Executive Summary

Two 10% owners (Vivo Opportunity, LLC and ADAR1 Capital Management, LLC) purchased a combined $189K of INM stock in an 8-day window, representing ~4.7% of the company's $4M market cap. This is a highly material cluster buy from sophisticated investors at a micro-cap pharma with no analyst bullish coverage, suggesting conviction ahead of a potential catalyst.

Key Financial Metrics

Direction
buying
Total Value
$189.0K
Insiders
2

Actionable Insight

The magnitude of this cluster buy (4.7% of market cap from two 10% owners) is a strong bullish signal at a micro-cap with no analyst support. Monitor for upcoming press releases, pipeline updates, or financing announcements — the insiders may be positioning ahead of material news. The stock's low liquidity means even small volume could amplify moves.

Key Facts

  • Two 10% owners bought $189K total in open-market purchases over 8 days (May 13–20, 2026).
  • Total buy value equals ~4.7% of INM's $4M market cap, far exceeding the 2% materiality threshold.
  • Vivo Opportunity, LLC bought 51.1K shares at $1.56 ($80K) on May 20.
  • ADAR1 Capital Management, LLC bought 68.6K shares at $1.60 ($110K) on May 19.
  • INM has zero analyst buy ratings (3 Hold, 5 Sell/Strong Sell) and a $4M market cap.
  • Historical calibration shows cluster buys at this size are amplified by cross-filing context (all 22 rule pairs are amplifiers).

Financial Impact

$189K in insider purchases = 4.7% of $4M market cap

insider ownershipmarket cap

Risk Factors

  • Micro-cap pharma with $4M market cap is highly speculative and illiquid.
  • No analyst bullish coverage and 5 sell/strong sell ratings indicate fundamental challenges.
  • Historical T+20 performance on INM reports shows -29.76% average return, suggesting the stock has been a poor performer after prior signals.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (8 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INM-1781140524722
10 reports for INM
Performance horizon
50% Hit rate 3 of 6 directional calls best @ T+5▲ +19.19%Mar 20, 2026
Filters
Rows
Reports for INM — sortable, filterable
Type Now
Jun 11, 2026
4d ago
Insider Cluster
BULLISH ★ 7/10
$1.51 awaiting T+5awaiting T+5$1.51 (−0.00%)
Jun 10, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$1.51 awaiting T+5awaiting T+5$1.51 (+0.33%)
May 19, 2026
26d ago
425
MIXED ★ 7/10
$1.60 $1.69▲ +5.63%▲ +3.38%$1.51 (−5.63%)
May 19, 2026
26d ago
8-K
BULLISH ★ 8/10
$1.60 $1.69▲ +5.63%▲ +3.38%$1.51 (−5.63%)
May 19, 2026
27d ago
8-K
BEARISH ★ 7/10
$1.60 $1.66▼ −3.75%▼ −1.45%$1.51 (+5.63%)
Apr 27, 2026
6w ago
8-K
BEARISH ★ 8/10
$0.7010 $0.7480▼ −6.70%▼ −5.01%$1.51 (−115.41%)
Apr 3, 2026
10w ago
8-K
NEUTRAL ★ 3/10
$0.6950 $0.7130▲ +2.59%▼ −1.54%$1.51 (+117.27%)
Apr 3, 2026
10w ago
424B5
BEARISH ★ 8/10
$0.6950 $0.7130▼ −2.59%▲ +1.54%$1.51 (−117.27%)
Mar 31, 2026
10w ago
EFFECT
BEARISH ★ 7/10
$0.6450 $0.6470▼ −0.31%▲ +3.63%$1.51 (−134.11%)
Mar 20, 2026
12w ago
S-3
BEARISH ★ 7/10
$0.7610 $0.6150▲ +19.19%▲ +15.62%$1.51 (−98.42%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 3h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access